Ask an expert
Buy with confidence.
Contact our experts today.
Buy with confidence.
Contact our experts today.
Description
The SpeedySwab™ Rapid COVID-19 + Flu A&B Antigen Test offers a groundbreaking solution for the simultaneous detection of COVID-19, Influenza A, and Influenza B in just 15 minutes. This advanced point-of-care test, authorized under FDA Emergency Use Authorization (EUA), enables healthcare providers to make swift, informed decisions for patient care by differentiating between these common respiratory infections efficiently and accurately.
Features
- Dual Detection: Simultaneously identifies COVID-19, Flu A, and Flu B from a single nasal swab sample.
- Rapid Results: Delivers accurate results within 15 minutes, enhancing timely patient management.
- High Sensitivity: Clinical sensitivities of 92.6% for COVID-19, 82.9% for Flu A, and 90% for Flu B.
- Convenient Testing: Designed for easy use in clinical settings, with all necessary components included in each box.
- Improved Efficiency: Streamlines patient flow and reduces the need for multiple tests, saving time and resources.
Product Specifications
| Items Per Box: | 25 tests |
|---|---|
| Specimen Type: | Nasal Swab |
| Result Time: | 15 Minutes |
| Shelf Life: | Up to 15 Months |
|---|---|
| Clinical Sensitivity: | COVID-19 |
See any errors on this page? Let us know
Compare Similar Items
Comparison Chart
Price:
Manufacturer:
Customer Rating:
Staff Favorite
Sale
Frequently Asked Questions (FAQs)
The test uses lateral flow immunochromatographic technology to detect and differentiate between the antigens of COVID-19, Flu A, and Flu B from a nasal swab sample. Results are available in 15 minutes.
The test is intended for use by healthcare professionals for in-vitro diagnostic purposes. It is used for individuals showing symptoms of respiratory infections within the first five days of symptom onset.
The test has a shelf life of up to 18 months. Check the expiration date on the box before use.
The test has a clinical sensitivity of 92.6% for COVID-19, 82.9% for Flu A, and 90% for Flu B.
This test is authorized by the FDA under Emergency Use Authorization (EUA). It is not FDA approved or cleared, but it is authorized for the detection of SARS-CoV-2, influenza A, and influenza B.